RTW Biotech Opportunities (LSE:RTW) Institutional Ownership: 10.83% (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:RTW RTW Biotech Opportunities Ltd LSE:RTW
41 GF Score
Price $2.44
! 2 Warning Signs
View Full Analysis

What is RTW Biotech Opportunities Institutional Ownership?

RTW Biotech Opportunities LSE:RTW 41 Institutional Ownership is 10.83% as of Jul. 22, 2026. GuruFocus rates LSE:RTW with a GF Score™ of 41/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, RTW Biotech Opportunities's institutional ownership is 10.83%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, RTW Biotech Opportunities's Insider Ownership is 0.58%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, RTW Biotech Opportunities's Float Percentage Of Total Shares Outstanding is 0.00%.

RTW Biotech Opportunities Institutional Ownership Historical Data

* Premium members only.

The historical data trend for RTW Biotech Opportunities's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RTW Biotech Opportunities Institutional Ownership Chart

RTW Biotech Opportunities Historical Data

The historical data trend for RTW Biotech Opportunities can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 9.96 10.08 10.33 12.69 13.22 13.34 13.68 11.28 10.99 10.83
LSE:RTW
41GF Score
RTW Biotech Opportunities Ltd LSE:RTW
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RTW Biotech Opportunities Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 10.83% mean?
RTW Biotech Opportunities (LSE:RTW) has a Institutional Ownership of 10.83% as of Jul. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on RTW Biotech Opportunities and its competitors.
Is RTW Biotech Opportunities' Institutional Ownership too high?
RTW Biotech Opportunities' current Institutional Ownership is 10.83%. Overall, RTW Biotech Opportunities has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does RTW Biotech Opportunities' Institutional Ownership compare to BLK and BX?
RTW Biotech Opportunities' Institutional Ownership of 10.83% can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for an Asset Management company?
A good Institutional Ownership depends on the Asset Management industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on RTW Biotech Opportunities and its competitors. RTW Biotech Opportunities's current Institutional Ownership is 10.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RTW Biotech Opportunities stock overvalued right now?
RTW Biotech Opportunities (LSE:RTW) has a current Institutional Ownership of 10.83%. The current Institutional Ownership is 10.83%. RTW Biotech Opportunities' overall GF Score™ is 41/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For RTW Biotech Opportunities (LSE:RTW), the current Institutional Ownership is 10.83% as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RTW Biotech Opportunities Business Description

Address St Julian’s Avenue, 1st Floor, Royal Chambers, St Peter Port, GGY, GY1 3JX
RTW Biotech Opportunities Ltd is a life sciences and investment fund focused on identifying transformative assets with high growth potential across the biopharma and medtech sectors. It is powering medical breakthroughs that have the potential to transform the wellbeing of people around the world. Its portfolio includes Neurology, Oncology, Inflammation, Cardiovascular, Metabolic, Pulmonary, Ophthalmology, Rare Disease, and Other. Geographically it operates in USA & Canada, the Rest of World, and UK & EU, with the majority of the revenue deriving from USA & Canada.
41GF Score

Get the complete analysis for LSE:RTW

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.44
Price